From: Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?
Ref | Jadad score | Disorder | Meds | Age | Gen | Omega-3 fatty acid | Prep type | Duration | N | Outcomemeasure | Average baseline score | Δ | Statistical significance vs. placebo |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
25 | 4 | ADHD | 100% | 9 | 22% | 345 mg/day EPA | Crude Mixture | 4 months | 54 | CBC-Attention | 66 | +0.4 | No |
28 | 5 | ADHD | 15% | 9 | 20% | 100 mg/day EPA 512 mg/day DHA | Crude mixture in food | 2 months | 40 | #DSM-Attention | 9.5 | -1 | No |
 |  |  |  |  |  |  |  |  |  | #DSM-Hyperactivity | 2 | 0 | No |
29 | 5 | LD | NS | 10 | 20% | 186 mg/day EPA 480 mg/day DHA2 | Crude mixture | 12 weeks | 29 | CPRS DSM-Attention | 63 | -4.6 | Yes |
 |  |  |  |  |  |  |  |  |  | CPRS DSM-Hyperactivity | 67 | -1.0 | No |
30 | 3 | 'ADHD-like' | 79% | 10 | 12% | 80 mg/day EPA 480 mg/day DHA1 | Crude mixture | 4 months | 47 | PDBDS-Attention | 22 | +0.2 | No |
 |  |  |  |  |  |  |  |  |  | PDBDS-Hyperactivity | 22 | -0.6 | No |
32 | 5 | DCD | 0% | 9 | 33% | 558 mg/day EPA 174 mg/day DHA3 | Crude mixture | 12 weeks | 117 | CPRS DSM-Attention | 65 | -3.5 | Yes4 |
 |  |  |  |  |  |  |  |  |  | CPRS DSM-Hyperactivity | 61 | -3.8 | Yes4 |
 |  |  |  |  |  |  |  |  |  | Spelling age (months) | 94 | +5.4 | Yes |
 |  |  |  |  |  |  |  |  |  | Reading age (months) | 97 | +6.2 | Yes |
34 | 4 | Autism | 0% | 10 | 18% | 840 mg/day EPA 700 mg/day DHA | Crude mixture | 6 weeks | 13 | ABC-Hyperactivity | 29 | -7.0 | No |